Molecular and clinical diversity in primary central nervous system lymphoma
Hernández-Verdin, I., Kirasic, E., Wienand, K., Mokhtari, K., Eimer, S., Loiseau, H., Rousseau, A., Paillassa, J., Ahle, G., Lerintiu, F., Uro-Coste, E., Oberic, L., Figarella-Branger, D., Chinot, O., Gauchotte, G., Taillandier, L., Marolleau, J.-P., Polivka, M., Adam, C., Ursu, R., Schmitt, A., Barillot, N., Nichelli, L., Lozano-Sánchez, F., Ibañez-Juliá, M.-J., Peyre, M., Mathon, B., Abada, Y., Charlotte, F., Davi, F., Stewart, C., de Reyniès, A., Choquet, S., Soussain, C., Houillier, C., Chapuy, B., Hoang-Xuan, K., Alentorn, A.
Published in Annals of oncology (01.02.2023)
Published in Annals of oncology (01.02.2023)
Get full text
Journal Article
Tafasitamab lenalidomide in relapsed/refractory large B‐cell lymphomas: a multicentric real‐world French experience study
Paillassa, J., Degoutte, C., Oberic, L., Branche, N., Copin, M., Poullot, E., Laurent, C., Lacheretz, V., Haioun, C., Herbaux, C.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
EARLY CTDNA CLEARANCE AFTER CAR T‐CELL INFUSION PREDICTS OUTCOME IN PATIENTS WITH LARGE B‐CELL LYMPHOMA : RESULTS FROM ALYCANTE, A PHASE 2 LYSA STUDY
Delfau‐Larue, M., Viailly, P., Cartron, G., Morschhauser, F., Gros, F., Gastinne, T., Oberic, L., Bachy, E., Dulery, R., Feugier, P., Menard, C., Quelen, C., Pangault, C., Portugues, C., Gomes, L., Itti, E., Bailly, C., Lemonnier, F., Laurent, C., Houot, R.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
AXICABTAGENE CILOLEUCEL AS SECOND‐LINE THERAPY FOR LARGE B‐CELL LYMPHOMA IN TRANSPLANT‐INELIGIBLE PATIENTS: FINAL ANALYSIS OF ALYCANTE, A PHASE 2 LYSA STUDY
Houot, R., Bachy, E., Cartron, G., Gros, F., Morschhauser, F., Oberic, L., Gastinne, T., Feugier, P., Dulery, R., Thieblemont, C., Joris, M., Jardin, F., Choquet, S., Casasnovas, O., Brisou, G., Cheminant, M., Bay, J., Gutierrez, F. Llamas, Menard, C., Tarte, K., Delfau, M., Itti, E., Bailly, C., Al Tabaa, Y., Laurent, C., Lemonnier, F.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
VERY LONG‐TERM FOLLOW‐UP OF RITUXIMAB MAINTENANCE IN YOUNG PATIENTS WITH MANTLE CELL LYMPHOMA INCLUDED IN THE LYMA TRIAL, A LYSA STUDY
Sarkozy, C., Thieblemont, C., Oberic, L., Moreau, A., Bouabdallah, K., Damaj, G., Gastine, T., Ribrag, V., Casasnovas, O., Haioun, C., Houot, R., Jardin, F., Neste, E., Cheminant, M., Morschhauser, F., Callana, M., Ghesquieres, H., Gressin, R., Hermine, O., Le Gouill, S.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
Brigatinib in patients with ALK‐positive anaplastic large cell lymphoma who have failed brentuximab vedotin
Veleanu, L., Tesson, B., Lamant, L., Marçais, A., Bruneau, J., Kaltenbach, S., Brouzes, C., Degoutte, C., Moraly, J., Villarese, P., Lhermitte, L., Latiri, M., Hure, G., Chauchet, A., Delette, C., Grosleron, S., Toussaint, E., Cabrera, Q., Brice, P., Gros, F., Clavert, A., Oberic, L., Le Goff, M., Cereja, S., Meggetto, F., Macintyre, E., Asnafi, V., Sibon, D.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
Rituximab-cyclophosphamide-dexamethasone combination in the management of autoimmune cytopenias associated with chronic lymphocytic leukemia
ROSSIGNOL, J, MICHALLET, A.-S, OBERIC, L, PICARD, M, GARON, A, WILLEKENS, C, DULERY, R, LELEU, X, CAZIN, B, YSEBAERT, L
Published in Leukemia (01.03.2011)
Published in Leukemia (01.03.2011)
Get full text
Journal Article
Hepatitis E virus infection and ribavirin treatment in patients with chronic lymphocytic leukemia receiving ibrutinib
Protin, C, Abravanel, F, Laurent, G, Tavitian, S, Oberic, L, Izopet, J, Martin-Blondel, G, Ysebaert, L, Alric, L
Published in Journal of hepatology (2017)
Published in Journal of hepatology (2017)
Get full text
Journal Article
Allogeneic stem cell transplantation for patients with mantle cell lymphoma who failed autologous stem cell transplantation: a national survey of the SFGM-TC
Tessoulin, B, Ceballos, P, Chevallier, P, Blaise, D, Tournilhac, O, Gauthier, J, Maillard, N, Tabrizi, R, Choquet, S, Carras, S, Ifrah, N, Guillerm, G, Mohty, M, Tilly, H, Socie, G, Cornillon, J, Hermine, O, Daguindau, É, Bachy, E, Girault, S, Marchand, T, Oberic, L, Reman, O, Leux, C, Le Gouill, S
Published in Bone marrow transplantation (Basingstoke) (01.09.2016)
Published in Bone marrow transplantation (Basingstoke) (01.09.2016)
Get full text
Journal Article
Efficacy of anti‐PD1 therapy in relapsed or refractory NK/T cell lymphoma: a matched cohort analysis from the LYSA
Marouf, A., Chaubard, S., Michot, J., Liévin, R., Rossignol, J., Golfier, C., Allangba, O., Philippe, L., Tessoulin, B., Chauchet, A., Deau, B., Oberic, L., Vargaftig, J., Moignet, A., Clavert, A., Dulery, R., Brisou, G., Tardy, S., Fataccioli, V., Houot, R., Casasnovas, R., Thieblemont, C., Ghesquières, H., Carras, S., Le Gouill, S., Cartron, G., Marabelle, A., Tournilhac, O., Damaj, G., Gaulard, P., Leval, L., Lemonnier, F., Bachy, E., Hermine, O., Couronné, L., Jaccard, A.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
LONG‐TERM OUTCOMES OF ELDERLY PATIENTS TREATED WITH FRONTLINE R‐CHOP: UPDATE OF THE LNH03‐6B TRIAL
Camus, V., Belot, Aurél., Oberic, L., Sibon, D., Ghesquières, H., Thieblemont, C., Fruchart, C., Casasnovas, O., Michot, Jean‐M., Molina, T. J., Bosly, A., Joubert, Clém., Haioun, C., Delarue, R., Tilly, H.
Published in Hematological oncology (01.06.2021)
Published in Hematological oncology (01.06.2021)
Get full text
Journal Article
Nodular lymphocyte predominant Hodgkin lymphoma: a Lymphoma Study Association retrospective study
Lazarovici, Julien, Dartigues, Peggy, Brice, Pauline, Obéric, Lucie, Gaillard, Isabelle, Hunault-Berger, Mathilde, Broussais-Guillaumot, Florence, Gyan, Emmanuel, Bologna, Serge, Nicolas-Virelizier, Emmanuelle, Touati, Mohamed, Casasnovas, Olivier, Delarue, Richard, Orsini-Piocelle, Frédérique, Stamatoullas, Aspasia, Gabarre, Jean, Fornecker, Luc-Matthieu, Gastinne, Thomas, Peyrade, Fréderic, Roland, Virginie, Bachy, Emmanuel, André, Marc, Mounier, Nicolas, Fermé, Christophe
Published in Haematologica (Roma) (01.12.2015)
Published in Haematologica (Roma) (01.12.2015)
Get full text
Journal Article
HIGH‐RISK MANTLE CELL LYMPHOMA IN THE LYMA TRIAL: A LYSA STUDY
Cheminant, M., Burroni, B., Le Bris, Y., Chartier, L., Oberic, L., Ribrag, V., Delfau, M.‐H., Thieblemont, C., Gressin, R., Canioni, D., Peyre, M., Laurent, C., Steimle, T., Kaltenbach, S., Asnafi, V., Macintyre, E., Callanan, M., Le Gouill, S., Hermine, O.
Published in Hematological oncology (01.06.2021)
Published in Hematological oncology (01.06.2021)
Get full text
Journal Article
Impact of dose intensity on outcome of fludarabine, cyclophosphamide, and rituximab regimen given in the first-line therapy for chronic lymphocytic leukemia
Bouvet, Emmanuelle, Borel, Cécile, Obéric, Lucie, Compaci, Gisèle, Cazin, Bruno, Michallet, Anne-Sophie, Laurent, Guy, Ysebaert, Loic
Published in Haematologica (Roma) (01.01.2013)
Published in Haematologica (Roma) (01.01.2013)
Get full text
Journal Article
ACALABRUTINIB MONOTHERAPY IN PATIENTS WITH RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA: FINAL RESULTS FROM A PHASE 2 STUDY
Wang, M., Rule, S., Zinzani, P. L., Goy, A., Casasnovas, O., Smith, S. D., Damaj, G., Doorduijn, J. K., Lamy, T., Morschhauser, F., Panizo, C., Shah, B., Davies, A., Eek, R., Dupuis, J., Jacobsen, E., Kater, A. P., Le Gouill, S., Oberic, L., Robak, T., Jain, P., Calvo, R., Tao, L., Dlugosz‐Danecka, M.
Published in Hematological oncology (01.06.2021)
Published in Hematological oncology (01.06.2021)
Get full text
Journal Article
IBRUTINIB ABOVE 79 YEARS OLD FOR CHRONIC LYMPHOCYTIC LEUKEMIA: IMPORTANT TOXICITIES
Calleja, A., Branco, B., Teste, A., Bijou, F., Clavert, A., Brion, A., Laribi, K., Oberic, L., Guieze, R., Michallet, A., Ysebaert, L.
Published in Hematological oncology (01.06.2019)
Published in Hematological oncology (01.06.2019)
Get full text
Journal Article
OBINUTUZUMAB PLUS DHAP FOLLOWED BY AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT) PLUS OBINUTUZUMAB MAINTENANCE PROVIDES A HIGH MRD RESPONSE RATE IN UNTREATED MCL PATIENTS. RESULTS OF LYMA‐101 TRIAL, A LYSA GROUP STUDY
Le Gouill, S., Beldi‐Ferchiou, A., Cacheux, V., Salles, G., Canioni, D., Bodet‐Milin, C., Alcantara, M., Delwail, V., Gastinne, T., Thieblemont, C., Maisonneuve, H., Lamy de la Chapelle, T., Oberic, l., Bouabdallah, K., Ribrag, V., Delfau‐Larue, M., Macintyre, E., Hermine, O.
Published in Hematological oncology (01.06.2019)
Published in Hematological oncology (01.06.2019)
Get full text
Journal Article
HIGH TOTAL METABOLIC TUMOR VOLUME AT BASELINE ALLOWS TO DISCRIMINATE FOR SURVIVAL PATIENTS IN RESPONSE AFTER R‐CHOP: AN ANCILLARY ANALYSIS OF THE REMARC STUDY
Cottereau, A., Vercellino, L., Casasnovas, O., Tilly, H., Feugier, P., Fruchart, C., Roulin, L., Oberic, L., Pica, G., Ribrag, V., Abraham, J., Simon, M., Gonzalez, H., Bouabdallah, R., Fitoussi, O., Sebban, C., Lopez, A., Macro, M., Sahnes, L., Morschhauser, F., Trotman, J., Corront, B., Choufi, B., Snauwaert, S., Godmer, P., Copie‐Bergman, C., Briere, J., Salles, G., Gaulard, P., Meignan, M., Thieblemont, C.
Published in Hematological oncology (01.06.2019)
Published in Hematological oncology (01.06.2019)
Get full text
Journal Article
REMARC STUDY: CORRELATION OF LYMPHOMA PD AND DEATH AND HEALTH‐RELATED QOL WITH MAINTENANCE LENALIDOMIDE VS PLACEBO IN ELDERLY DLBCL PATIENT RESPONDERS TO R‐CHOP
Thieblemont, C., Casasnovas, R., Mounier, N., Perrot, A., Morschhauser, F., Tilly, H., Fruchart, C., Corront, B., Haouin, C., Van Eygen, K., Obéric, L., Bouabdallah, R., Sebban, C., Bordessoule, D., Fitoussi, O., Van Hoof, A., Eisenmann, J.C., Lionne‐Huyghe, P., Deeren, D., Gomes Da Silva, M., Trotman, J., Grosicki, S., Greil, R., Caballero, D., Coiffier, B.
Published in Hematological oncology (01.06.2017)
Published in Hematological oncology (01.06.2017)
Get full text
Journal Article